☰ Navigation Tabs
Beta-endorphin amyloid fibril
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D CHHC 2 mg/mL [U-100% 13C; U-100% 15N] beta-endorphin, 90 % H2O, 10 % [U-2H] D2O 90% H2O/10% D2O n.a. 5.5 AMBIENT Pa 273 Bruker AVANCE 850 2 2D PAR 2 mg/mL [U-100% 13C; U-100% 15N] beta-endorphin, 90 % H2O, 10 % [U-2H] D2O 90% H2O/10% D2O n.a. 5.5 AMBIENT Pa 273 Bruker AVANCE 850 3 2D PDSD 2 mg/mL [U-100% 13C; U-100% 15N] beta-endorphin, 90 % H2O, 10 % [U-2H] D2O 90% H2O/10% D2O n.a. 5.5 AMBIENT Pa 273 Bruker AVANCE 850
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE 850
NMR Refinement Method Details Software torsion angle dynamics CYANA
NMR Ensemble Information Conformer Selection Criteria target function Conformers Calculated Total Number 95 Conformers Submitted Total Number 10 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 structure calculation CYANA 3.98.3 Guentert, P. 2 chemical shift assignment CcpNmr Analysis CCPN